Vaxcyte, Inc. (PCVX)
NASDAQ
Market Cap
$8.17B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
700 of 809
Rank in Industry
380 of 445
Largest Insider Buys in Sector
PCVX Stock Price History Chart
PCVX Stock Performance
About Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Insider Activity of Vaxcyte, Inc.
Over the last 12 months, insiders at Vaxcyte, Inc. have bought $0 and sold $28.69M worth of Vaxcyte, Inc. stock.
On average, over the past 5 years, insiders at Vaxcyte, Inc. have bought $41.38M and sold $35.83M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 186,000 shares for transaction amount of $2.98M was made by Hopfner Robert Lorne (director) on 2020‑06‑16.
List of Insider Buy and Sell Transactions, Vaxcyte, Inc.
| 2024-06-24 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 15,000 0.0138% | $75.64 | $1.13M | -1.69% | |
| 2024-06-18 | Sale | GUGGENHIME ANDREW | PRESIDENT AND CFO | 8,000 0.0073% | $71.92 | $575,375 | +3.42% | |
| 2024-06-03 | Sale | Wassil Jim | CHIEF OPERATING OFFICER | 3,000 0.0027% | $71.99 | $215,961 | +0.72% | |
| 2024-06-03 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 2,616 0.0024% | $72.06 | $188,512 | +0.72% | |
| 2024-06-03 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 2,392 0.0022% | $71.93 | $172,063 | +0.72% | |
| 2024-06-03 | Sale | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $72.06 | $120,127 | +0.72% | |
| 2024-06-03 | Sale | Gilbert Halley E | director | 18,200 0.0169% | $73.00 | $1.33M | +0.72% | |
| 2024-05-23 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 15,000 0.0138% | $69.43 | $1.04M | +4.33% | |
| 2024-05-20 | Sale | GUGGENHIME ANDREW | PRESIDENT AND CFO | 8,000 0.0073% | $74.99 | $599,909 | -4.85% | |
| 2024-05-01 | Sale | Wassil Jim | CHIEF OPERATING OFFICER | 3,000 0.0027% | $61.65 | $184,942 | +12.55% | |
| 2024-05-01 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 2,616 0.0023% | $61.70 | $161,419 | +12.55% | |
| 2024-05-01 | Sale | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $61.74 | $102,921 | +12.55% | |
| 2024-04-23 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 15,000 0.014% | $61.92 | $928,845 | +16.52% | |
| 2024-04-18 | Sale | GUGGENHIME ANDREW | PRESIDENT AND CFO | 8,000 0.0075% | $61.27 | $490,199 | +15.89% | |
| 2024-04-01 | Sale | Wassil Jim | CHIEF OPERATING OFFICER | 3,000 0.0028% | $66.69 | $200,066 | +1.05% | |
| 2024-04-01 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 2,616 0.0024% | $66.71 | $174,502 | +1.05% | |
| 2024-04-01 | Sale | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | 1,667 0.0015% | $66.73 | $111,234 | +1.05% | |
| 2024-03-25 | Sale | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 15,000 0.014% | $66.93 | $1M | +1.60% | |
| 2024-03-18 | Sale | GUGGENHIME ANDREW | PRESIDENT AND CFO | 8,000 0.0075% | $69.02 | $552,144 | -0.80% | |
| 2024-03-01 | Sale | Wassil Jim | CHIEF OPERATING OFFICER | 3,000 0.0028% | $73.71 | $221,134 | -4.74% |
Insider Historical Profitability
<0.0001%
| Wassil Jim | CHIEF OPERATING OFFICER | 213503 0.1658% | $75.05 | 0 | 17 | |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 478888 0.1414% | $75.05 | 0 | 50 | |
| GUGGENHIME ANDREW | PRESIDENT AND CFO | 96720 0.0749% | $75.05 | 0 | 20 | |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | 31161 0.0195% | $75.05 | 0 | 8 | |
| Cowan Elvia | SVP, FINANCE | 12480 0.0115% | $75.05 | 0 | 1 | |
| Lukatch Heath | director | 5625 0.0053% | $75.05 | 0 | 7 | |
| Gilbert Halley E | director | 5625 0.0052% | $75.05 | 0 | 1 | |
| TPG Group Holdings (SBS) Advisors, Inc. | 5074574 4.7832% | $75.05 | 1 | 1 | <0.0001% | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 5001593 4.7144% | $75.05 | 0 | 5 | |
| EMSTER KURT VON | director | 4168718 3.9294% | $75.05 | 1 | 0 | <0.0001% |
| Heron Patrick J | director | 2309554 2.177% | $75.05 | 1 | 0 | <0.0001% |
| Hopfner Robert Lorne | director | 1405418 1.3247% | $75.05 | 1 | 21 | <0.0001% |
| Fairman Jeff | VP, Research | 286227 0.2698% | $75.05 | 0 | 20 | |
| Sauer Paul | SVP Process Dev, Manufacturing | 14687 0.0138% | $75.05 | 0 | 13 | |
| Wright-Mitchell Jane | General Counsel | 3125 0.0029% | $75.05 | 0 | 5 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Fidelity Investments | $1.11B | 14.95 | 16.26M | +14.41% | +$139.88M | 0.07 | |
| The Vanguard Group | $665.15M | 8.95 | 9.74M | +15.2% | +$87.77M | 0.01 | |
| BlackRock | $649.83M | 8.74 | 9.51M | +10.93% | +$64.02M | 0.02 | |
| RA Capital Management, L.P. | $560.4M | 7.54 | 8.2M | +3.96% | +$21.35M | 0.56 | |
| Janus Henderson | $524.12M | 7.05 | 7.67M | +9.92% | +$47.3M | 0.29 | |
| Wellington Management Company | $336.04M | 4.52 | 4.92M | +11% | +$33.3M | 0.06 | |
| Capital Research Global Investors | $282.84M | 3.81 | 4.14M | +20.36% | +$47.85M | 0.06 | |
| T Rowe Price Investment Management Inc | $242.7M | 3.27 | 3.55M | +185.14% | +$157.59M | 0.15 | |
| State Street | $227.96M | 3.07 | 3.34M | -1.55% | -$3.58M | 0.01 | |
| T. Rowe Price | $216.97M | 2.92 | 3.18M | +18.61% | +$34.04M | 0.03 | |
| Darwin Global Management Ltd | $187.91M | 2.53 | 2.75M | +374.31% | +$148.29M | 27.94 | |
| Geode Capital Management | $156.27M | 2.1 | 2.29M | +15.9% | +$21.44M | 0.01 | |
| Franklin Templeton Investments | $146.71M | 1.97 | 2.15M | +99.43% | +$73.14M | 0.04 | |
| Perceptive Advisors | $132.03M | 1.78 | 1.93M | +77.56% | +$57.67M | 0.09 | |
| Driehaus Capital Management LLC | $127.59M | 1.72 | 1.87M | +11.55% | +$13.21M | 1.28 | |
| AllianceBernstein | $121.64M | 1.64 | 1.78M | -7.01% | -$9.18M | 0.04 | |
| Westfield Capital Management Co Lp | $108.35M | 1.46 | 1.59M | +8.97% | +$8.91M | 0.57 | |
| Alger | $95.41M | 1.28 | 1.4M | -16.37% | -$18.68M | 0.47 | |
| JENNISON ASSOCIATES LLC | $85.86M | 1.16 | 1.26M | -14.85% | -$14.98M | 0.06 | |
| Paradigm BioCapital Advisors LP | $84.7M | 1.14 | 1.24M | New | +$84.7M | 3.07 | |
| Invesco | $84.33M | 1.14 | 1.23M | +443.95% | +$68.83M | 0.02 | |
| Braidwell Lp | $82.84M | 1.12 | 1.21M | -5.99% | -$5.28M | 4.67 | |
| JPMorgan Chase | $79.36M | 1.07 | 1.16M | +186.62% | +$51.67M | 0.01 | |
| Frazier Life Sciences Management L P | $77.83M | 1.05 | 1.14M | -2.15% | -$1.71M | 4 | |
| OrbiMed | $72.83M | 0.98 | 1.07M | -7.54% | -$5.94M | 1.49 | |
| Northern Trust | $66.18M | 0.89 | 968,757 | +9.55% | +$5.77M | 0.01 | |
| Commodore Capital, LP | $58.75M | 0.79 | 860,000 | -21.82% | -$16.39M | 4.14 | |
| Novo Holdings A/S | $57.72M | 0.78 | 845,000 | 0% | +$0 | 4.03 | |
| Charles Schwab | $56.94M | 0.77 | 833,618 | +14.13% | +$7.05M | 0.01 | |
| Pivotal Bioventure Partners Investment Advisor Llc | $54.17M | 0.73 | 793,036 | 0% | +$0 | 39.73 | |
| Kynam Capital Management Lp | $50.89M | 0.69 | 745,000 | -25.68% | -$17.58M | 0.64 | |
| Goldman Sachs | $47.71M | 0.64 | 698,492 | +45.18% | +$14.85M | 0.01 | |
| Cormorant Asset Management Lp | $46.79M | 0.63 | 685,000 | +3.01% | +$1.37M | 2.22 | |
| Eventide Asset Management | $44.89M | 0.6 | 657,206 | +8.23% | +$3.42M | 0.71 | |
| Avoro Capital Advisors Llc | $39.28M | 0.53 | 575,000 | New | +$39.28M | 0.47 | |
| Morgan Stanley | $33.5M | 0.45 | 490,454 | -8.73% | -$3.2M | <0.01 | |
| Ensign Peak Advisors Inc | $32.5M | 0.44 | 475,700 | +31.73% | +$7.83M | 0.06 | |
| American Century Investments | $31.54M | 0.42 | 461,724 | +13.38% | +$3.72M | 0.02 | |
| Federated Hermes | $29.08M | 0.39 | 425,750 | +8.01% | +$2.16M | 0.07 | |
| BNY Mellon | $28.18M | 0.38 | 412,525 | +3.36% | +$915,900.52 | 0.01 | |
| Woodline Partners LP | $26.89M | 0.36 | 393,704 | +0.09% | +$24,113.43 | 0.25 | |
| Lord Abbett | $26.26M | 0.35 | 384,363 | -0.31% | -$82,723.93 | 0.09 | |
| Farallon Capital | $25.78M | 0.35 | 377,400 | +11,000% | +$25.55M | 0.18 | |
| D. E. Shaw & Co. | $25.09M | 0.34 | 367,249 | -16.21% | -$4.85M | 0.03 | |
| Maverick Capital Ltd | $24.26M | 0.33 | 355,131 | New | +$24.26M | 0.47 | |
| HERITAGE ASSET MANAGEMENT INC | $22.61M | 0.31 | 338,800 | -4.33% | -$1.02M | 0.12 | |
| Nuveen | $21.27M | 0.29 | 311,352 | +10.86% | +$2.08M | 0.01 | |
| Amundi | $18.33M | 0.28 | 302,357 | -8.32% | -$1.66M | 0.01 | |
| Samlyn Capital, LLC | $20.68M | 0.28 | 302,679 | -8.06% | -$1.81M | 0.36 | |
| Ecor1 Capital Llc | $20.49M | 0.28 | 300,000 | New | +$20.49M | 0.52 |